SELLAS Life Sciences Group, Inc. (SLS) Operating cash flow 2016–2025
SELLAS Life Sciences Group, Inc. (SLS) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$28.4MFY2025 · since FY2016: -$11.8M → -$28.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$28.4M | +19.8% |
| FY2024 | -$35.4M | -12.7% |
| FY2023 | -$31.4M | -31.9% |
| FY2022 | -$23.8M | +8.5% |
| FY2021 | -$26.0M | -149.8% |
| FY2020 | -$10.4M | +41.0% |
| FY2019 | -$17.6M | +42.0% |
| FY2018 | -$30.4M | -176.8% |
| FY2017 | -$11.0M | +7.3% |
| FY2016 | -$11.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice